Serge Ruden

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The identification of lead molecules against multidrug-resistant bacteria ensuing the development of novel antimicrobial drugs is an urgent task. Proline-rich antimicrobial peptides are highly active in vitro and in vivo, but only against a few Gram-negative human pathogens, with rather weak activities against Pseudomonas aeruginosa and Staphylococcus(More)
  • 1